ArticleIndian pediatrics2026
Clinical and Antimicrobial Resistance Patterns of Salmonella enterica Serovar Paratyphi A Infections in Pediatric Population.
Article in Indian pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to analyze the clinical profiles, antibiotic susceptibility patterns and biochemical characteristics of Salmonella enterica serovar Paratyphi A (SPA) infections in children.
methodsA retrospective observational study was conducted on hospitalized pediatric patients (< 18 years) admitted with blood culture-confirmed SPA infection between January 2022 and October 2024. Data on demographics, clinical features, treatment regimens, antibiotic susceptibility and outcomes were extracted from medical records. Statistical analyses were performed using SPSS, with P < 0.05 considered significant.
resultsForty-five cases were included, with a mean (SD) age of 7 (4.3) years. Fever was universal (100%), accompanied by vomiting (46.7%) and abdominal pain (44.4%). Hepatomegaly and splenomegaly were observed in 46.7 and 42.2% of the cases, respectively. Third-generation cephalosporins were the most commonly used antibiotics (95.6%), but resistance to ceftriaxone was significant (31%). Fluoroquinolone resistance was found in 85-100% of the isolates. Trimethoprim + sulfamethoxazole (100%) and chloramphenicol (90.6%) exhibited the highest susceptibilities. Extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase production were detected in 35.6% and 26.7% of isolates, respectively.
conclusionEmerging antimicrobial resistance was observed among pediatric SPA isolates; however, short-term clinical outcomes were favorable, with good response to appropriately tailored antimicrobial therapy.
Indexed as
Identifiers
42329350What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.